Mr. Chen joined Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE) in 1994. He is an executive director and chairman of Fosun Pharma and an executive-director and a co-president of Fosun International. He has been a non-executive director and vice chairman of Sinopharm (listed on the Hong Kong Stock Exchange), a non-executive director of Babytree (listed on the Hong Kong Stock Exchange), a director of Sanyuan Foods (listed on the SSE) and various companies within the Group.
Mr. Chen was a director of Maxigen Biotech Inc. (listed on the Taiwan Stock Exchange) and a director of Dian Diagnostics Group Co.,Ltd. (listed on Shenzhen Stock Exchange).
Mr. Chen has been the chairman of China Medical Pharmaceutical Material Association, a vice president of China Pharmaceutical Innovation and Research Development Association, the chairman of Shanghai BioPharmaceutical Industry Association and the vice council chairman of Shanghai Society of Genetics.
Mr. Chen received a bachelor’s degree in genetics from Fudan University in 1993 and an EMBA degree from China Europe International Business School in 2005.